|
BioFocus is to acquire Cambridge Drug Discovery, the drug screening specialist, for £27m, in order to offer a wider range of services to the pharmaceutical industry. 24-May-2001 Cambridge Drug Discovery is to collaborate with Teijin of Japan to develop new treatments for diabetes and obesity. 25-Apr-2000 Cambridge Drug Discovery has merged with Cambridge Genetics in a £2.7m deal involving Cambridge University, and the combined business will have 36 staff. 11-Jan-2000
|